Skip to content
Medical Health Aged Care

New data supports current management of CO2 levels in cardiac arrest patients

Monash University 3 mins read

A promising emerging treatment for comatose adult cardiac arrest patients has yielded similar results to current treatments in a Monash University-led study published in The New England Journal of Medicine.

Out-of-hospital cardiac arrests (OHCA) cause significant death and disability, the study was one the largest trials conducted on cardiac arrest patients admitted to intensive care units.


The Targeted Therapeutic Mild Hypercapnia After Resuscitated Cardiac Arrest (TAME) study showed that maintaining a slightly elevated carbon dioxide (CO2) level (hypercapnia) for the first 24 hours after a cardiac arrest patient has been resuscitated did not improve neurological outcomes, functional outcomes, or quality of life at six months after the event, and did not impact six-month mortality. 


TAME leader 
Dr Glenn Eastwood said conversely it did not lead to worse outcomes, either. Dr Eastwood said previous observational studies had shown that while many doctors followed guidelines and kept the CO2 level normal, it was common to have hypercapnia. 


He said these studies suggested hypercapnia was associated with improved outcomes, and there were many physiological reasons why this might be so, including increasing blood flow.


TAME researchers had also conducted an earlier smaller trial that suggested that hypercapnia improved outcomes, but recognised the need for a large trial to confirm this finding.


“It was a really interesting hypothesis to test, as if it had shown positive results, the change in practice would have been free of cost, beyond those associated with change implementation, Dr Eastwood said. “But our study provides the strongest evidence to date, and indicates no benefit to changing current practice.”


The TAME randomised controlled trial recruited 1,700 patients from 63 intensive care units in 17 countries, in a uniquely harmonised system that saw them partner with another clinical trial in Sweden


Hospitalised comatose adults resuscitated from out-of-hospital cardiac arrest of a presumed cardiac or unknown cause with sustained return of spontaneous circulation were eligible for enrolment. A total of 847 patients (49.8 per cent) were assigned to targeted mild hypercapnia and 853 (50.2 per cent) to targeted standard care (normocapnia).


The primary outcome was a favourable neurological outcome defined by a Glasgow Outcome Scale-Extended score of 5 to 8 at six months, obtained by blinded assessors. Secondary outcomes were similarly measured at six months by other relevant, validated scales.


“There’s three main ways our study impacts practice and research,” Dr Eastwood said 

“Firstly, while we found no additional harm from pursuing hypercapnia in these patients, the lack of benefit means there’s no need to change practice – it would be a waste of time and resources. So, doctors can rest assured that patients aren’t missing out if they receive standard practice.


“The second is that while we are somewhat disappointed we haven't discovered a new therapy for these patients, we demonstrated that these patients can tolerate hypercapnia without causing any harm. This can be important in ICU settings, as this allows doctors to less intensely ventilate patients on breathing machines, which can be helpful in some patient groups.


“Thirdly, it points to a need for further trials and basic science research, as we seem to have a gap in our knowledge and theories about the role of arterial CO2, and how it impacts the body’s responses.

“Relevant work is being now conducted, to determine what blood markers can determine good outcomes and allow identification of these patients earlier. We’ve also established a global network of OHCA hospitals and investigators which are now turning to answer the next important question in this patient group.”


The results were published in the journal in a coordinated release with the Critical Care Reviews 2023 Meeting in Belfast.


For media enquiries please contact:

Monash University

Cheryl Critchley - Communications Manager (medical)
E: cheryl.critchley@monash.edu 

T: +61 (0) 418 312 596

For more Monash media stories, visit our news and events site  


For general media enquiries please contact:
Monash Media
E: media@monash.edu
T: +61 (0) 3 9903 4840

 

***ENDS***

 

More from this category

  • Medical Health Aged Care
  • 15/06/2024
  • 04:30
Dementia Australia

Join us TODAY for Hunter Walk & Jog

What: Dementia Australia’sHunterMemory Walk & Jog. When: Saturday 15 June from 7.30am. Who: More than 750 locals participating on the day. People who have been impacted by dementia, their family, friends and carers. Where: Speers Point Park, Speers Point For more information visit: www.memorywalk.com.au Walk or jog with us. We are in this together. Dementia Australia is the source of trusted information, education and services for the estimated more than 421,000 Australians living with dementia, and the more than 1.6 million people involved in their care. We advocate for positive change and support vital research. We are here to support…

  • Contains:
  • Medical Health Aged Care
  • 14/06/2024
  • 22:07
Takeda Pharmaceutical Company Limited

Takeda Signs Option Agreement with Ascentage Pharma to Enter into Exclusive Global License for Olverembatinib, a Third-Generation BCR-ABL Tyrosine Kinase Inhibitor (TKI)

− Takeda to Receive Exclusive Option to License Global Rights to Olverembatinib in All Territories Outside of Mainland China, Hong Kong, Macau, Taiwan and…

  • Contains:
  • Disability, Medical Health Aged Care
  • 14/06/2024
  • 09:44
Audika

NEGLECTED SENSE: 73% ADMIT HEARING FALLS BEHIND SIGHT IN ATTENTION

A new survey commissioned by hearing care expertsAudika Hearing Clinic reveals surveyed Australians prioritise their sight over hearing, despite over three quarters (77%) knowing someone who is hard of hearing. Most (86%) respondents ranked sight as their most important sense, with hearing coming in second (69%)[1]. Unsurprisingly, this is reflected in which sense they care for more, with almost three quarters (73%) of respondents admitting that between hearing and sight, their hearing was the most neglected[1]. Reasons for neglect: Lack of understanding and stigma Both stigma and a lack of understanding can impact the way Australians prioritise their senses. Interestingly,…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.